艾昆纬 IQV 深 沪
等待开盘 07-01 09:30:00 美东时间
193.22
-0.060
-0.03%
华盛通- 最 高194.08
- 今 开194.00
- 成交量 135.75万股
- 最 低 188.915
- 昨 收 193.28
- 总市值 3224.84万
- 52周最高 247.045
- 市盈率 静 24.65
- 换手率 813.37%
- 52周最低 154.50
- 委 比 21.88%
- 总股本 0.00亿
- 历史最高 285.61
- 量 比 0.83
- 振 幅 2.67%
- 历史最低 81.79
- 每 手 1
- 风险率 24.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多从法律到制药！Anthropic推出Claude Science，旨在赋能科研自动化，加速药物发现进程
人工智能巨头Anthropic周一宣布，正式发布全新软件工具Claude Science，旨在帮助科研人员实现研究流程自动化，从而将科学家从繁琐重复的实验操作中...
今天 07:29
周三市值变动股涉及希捷和闪迪
周三美股多只个股出现大幅波动，覆盖超大盘股、大盘股、中盘股、小盘股多个市值区间。 各市值区间核心波动标的及行情数据： 超大盘股（市值≥2000亿美元）：希捷科...
06-25 02:37
美股大行评级 | 花旗维持美光科技"买入"评级！目标价从840美元升至1200美元
今日重点评级关注：Chardan Capital：维持SAB Biotherapeutics"买入"评级，目标价从14美元升至16美元；Northland Capital Markets：维持Applied Digital"跑赢大市"评级，目标价从56美元升至82美元
06-18 19:08
Morgan Stanley Downgrades IQVIA Holdings to Equal-Weight, Lowers Price Target to $200
Morgan Stanley analyst Kallum Titchmarsh downgrades IQVIA Holdings (NYSE:IQV) from Overweight to Equal-Weight and lowers the price target from $225 to $200.
06-17 20:59
Citrini看多美股医疗板块新行情，更新“卖铲人”篮子：AI利好叠加周期性改善，复苏信号更明确
曾凭借《2028年全球智能危机》这一“思想实验”报告迅速出圈的独立研究机构的Citrini Research近日对其医疗保健投资组合进行了更新，原因是该公司...
06-10 09:49
Novo Nordisk marks more than 3M Wegovy pill prescriptions
Novo Nordisk (NVO) says that prescriptions for its new oral weight loss therapy, the Wegovy pill, have exceeded 3M in just five months after its U.S. launch, a milestone for a company that is struggli...
06-09 21:55
EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch
Scienture expands Rezenopy access through a major health plan ahead of launch, adding coverage for more than 100 million lives.
06-09 19:46
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Amneal Pharmaceuticals received FDA approval for its ready-to-use romidepsin injection solution, offering a convenient alternative to lyophilized powder. As a Competitive Generic Therapy, it secures 180 days of market exclusivity and strengthens Amneal's injectables portfolio. The product eliminates reconstitution steps, improving safety and efficiency for healthcare providers. Romidepsin is indicated for cutaneous T-cell lymphoma and has common ...
06-04 12:00
IQVIA Announces €950 Million Senior Notes Offering
IQVIA Holdings ( ($IQV) ) has shared an announcement. On June 3, 2026, IQVIA Ho...
06-04 06:22
